Daytona Beach, FLORIDA2 Active Studies

Ankylosing Spondylitis Clinical Trials in Daytona Beach, FLORIDA

Find 2 actively recruiting ankylosing spondylitis clinical trials in Daytona Beach, FLORIDA. Connect with local research sites and explore new treatment options.

2
Active Trials
2
Sponsors
1,104
Enrolling

Recruiting Ankylosing Spondylitis Studies in Daytona Beach

About Ankylosing Spondylitis Clinical Trials in Daytona Beach

Ankylosing spondylitis is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, causing pain, stiffness, and potentially spinal fusion. It typically begins in early adulthood. Treatment includes NSAIDs, biologics (TNF and IL-17 inhibitors), and physical therapy.

There are currently 2 ankylosing spondylitis clinical trials recruiting participants in Daytona Beach, FLORIDA. These studies are seeking a combined 1,104 participants. Research is being sponsored by ACADIA Pharmaceuticals Inc., Ventus Therapeutics U.S., Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.

Ankylosing Spondylitis Clinical Trials in Daytona Beach — FAQ

Are there ankylosing spondylitis clinical trials in Daytona Beach?

Yes, there are 2 ankylosing spondylitis clinical trials currently recruiting in Daytona Beach, FLORIDA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Daytona Beach?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Daytona Beach research site will contact you about next steps.

Are clinical trials in Daytona Beach free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Daytona Beach studies also compensate for your time and travel.

What ankylosing spondylitis treatments are being tested?

The 2 active trials in Daytona Beach are testing new therapies including novel drugs, biologics, and treatment approaches for ankylosing spondylitis.

Data updated March 2, 2026 from ClinicalTrials.gov